Insys (INSY) Initiates Phase 3 Trial of Cannabidiol Oral Solution for Treatment of Infantile Spasms
March 2, 2018 8:32 AM
INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
